Business · 17/09/2012
FDA Corrects Document with Incorrect Email Address for Regulatory New Drug Review Meeting
The Food and Drug Administration (FDA) is correcting a document that appeared in the Federal Register of August 14, 2012, to correct an incorrect email address. The document, which announced a meeting on Regulatory New Drug Review: Solutions for Study Data Exchange Standards, was published with the incorrect contact information.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →